Bernd R. Seizinger insider trades: Oncolytics Biotech (ONCY) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Bernd reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | ONCY | ↑ Buy | 100,000 | $0.83 | $83K | Direct | Feb 13, 2026 (1d) |
| Jan 16, 2026 | ONCY | ↑ Buy | 100,000 | $1.04 | $104K | Direct | Jan 20, 2026 (4d) |
| Oct 11, 2024 | APRE | ↑ Buy | 10,000 | $2.68 | $27K | Direct | Oct 15, 2024 (4d) |
| Mar 13, 2024 | APRE | ↑ Buy | 6,860 | $7.29 | $50K | Direct | Mar 14, 2024 (1d) |
| Sep 22, 2023 | APTO | ↑ Buy | 17,000 | $3.14 | $53K | Direct | Sep 25, 2023 (3d) |
| Jun 7, 2023 | APRE | ↑ Buy | 10,097 | $3.66 | $37K | Direct | Jun 8, 2023 (1d) |
| May 18, 2022 | APRE | ↑ Buy | 50,000 | $0.71 | $36K | Direct | May 19, 2022 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ONCY insiders
Open-market trades in the last 12 months
About Bernd R. Seizinger's insider trades
Bernd R. Seizinger is a director at Oncolytics Biotech (ONCY). Since May 18, 2022, Bernd has reported 7 open-market purchases worth $390K and no sales on SEC Form 4. In the last 12 months: 2 buys ($187K).
Their filings also include grants and awards (11 filings), other transactions (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ONCY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.